Actos is a medication used to treat patients with type II diabetes by keeping their blood glucose levels down. The medication is a member of a class of drugs, but only Actos seems to be linked to an increased risk for developing bladder cancer according to a recent news feature form UPI. There is another drug in the same class of medications known as Avandia (brand name for rosigilatazone), but that drug, while chemically similar, does not appear to cause any increased risk of bladder cancer, as is the case with Actos. While it is normally an entire class of medications that has the common trait which causes a disease or other adverse health event, it is not unheard of for the problem to be drug specific, as is the case with Actos.
An example of an entire class of drugs that has been shown to cause serious health consequences is known as New Oral Anticoagulants (NOACs) like Eliquis, Xarelto, Savaysa, and Pradaxa. Continue reading
Product Liability Lawyer Blog











